Plus Therapeutics

American pharmaceutical company specializing in radiotherapeutics

Plus Therapeutics logo

Plus Therapeutics, Inc. is an American pharmaceutical company that focuses on the development and commercialization of innovative, targeted radiotherapeutics for patients with rare and difficult-to-treat cancers. The company is headquartered in Austin, Texas, and operates with a mission to improve the lives of patients through the development of novel therapies.

History

Plus Therapeutics was originally founded as a biotechnology company with a focus on developing nanomedicine-based therapies. Over the years, the company has evolved its focus towards radiotherapeutics, leveraging its expertise in drug development and delivery technologies. The shift towards radiotherapeutics was driven by the potential of these therapies to provide targeted treatment options for cancers that are otherwise challenging to treat.

Research and Development

The company's research and development efforts are centered around the use of radioisotopes to deliver targeted radiation therapy directly to cancer cells. This approach aims to minimize damage to surrounding healthy tissues, thereby reducing side effects and improving patient outcomes. Plus Therapeutics is actively involved in clinical trials to evaluate the safety and efficacy of its radiotherapeutic candidates.

Radiotherapeutic Platforms

Plus Therapeutics utilizes proprietary platforms to develop its radiotherapeutic products. These platforms are designed to enhance the delivery and targeting of radioisotopes to cancer cells. The company's lead product candidates are being developed for the treatment of glioblastoma, a highly aggressive form of brain cancer, and other solid tumors.

Products

The company's product pipeline includes several investigational radiotherapeutics that are in various stages of clinical development. These products are designed to address unmet medical needs in oncology by providing new treatment options for patients with limited alternatives.

Corporate Strategy

Plus Therapeutics' corporate strategy involves strategic partnerships and collaborations with leading academic institutions and research organizations. These partnerships are aimed at advancing the development of its radiotherapeutic candidates and expanding its pipeline.

Related pages

• Radiopharmaceutical
• Cancer treatment
• Biotechnology
• Nanomedicine